The global healthcare specialty enzymes market size is estimated to reach USD 3.8 billion by 2027, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 6.2% from 2020 to 2027. Increasing penetration of enzymes in medical applications serves to be a key driving factor for the market. This is also supplemented by extensive research studies being carried out to explore the potential of enzymes in diagnosis as well as therapy. Diagnostic serum enzymes have gained significant attention for the quantification of these offers useful insights regarding abnormal tissue or an organ and help in predicting sites that are susceptible to tissue damage.
Certain products such as aldolase, Creatine Phosphokinase (CPK), gamma-glutamyl transpeptidase, lactic dehydrogenase, lipase, and transaminases are routinely adopted for disease diagnosis. Aldolase is preferably used in the early-stage diagnosis of viral hepatitis as well as advanced prostate cancer. Whereas, CPK has caught the attention of healthcare professionals in terms of both diagnosis and research. CPK tests are performed to diagnose cardiac abnormalities, muscle-associated conditions along with differentiation of post-operative infection from malignant hyperthermia. Thus, the use of enzyme products expanding across various diagnostic applications is set to propel the demand for these products in the healthcare industry.
Enzyme dependent analytical procedures are carried out on a large scale; specificity and potency of these procedures enable amplification as well as detection of a specific target analyte. This has propelled the use of enzyme-based assays in the field of wet chemistry for the quantification of target substances and drugs. Soaring demand for immunodiagnostics, especially Enzyme-linked Immunosorbent Assay (ELISA) boosts the use of specialty enzymes in the amplification of the target signal. Whereas regular use of DNA polymerase for DNA amplification in DNA fingerprinting has increased considerably over the years.
Request a free sample copy or view report summary: Healthcare Specialty Enzymes Market Report
Carbohydrases accounted for the highest revenue share in 2019 and are anticipated to maintain this trend from 2020 to 2027
A major contribution to the revenue generated by this segment in the market is done by amylases and cellulases, as amylases are employed in several biotechnology applications
The phosphatase/phytase product segment is set to grow at the fastest pace from 2020 to 2027
This is attributed to the rise in use of alkaline phosphatases inclusive of zinc and magnesium ions, which is favored in pharmaceutical applications along with clinical analysis
The research and biotechnology end-use segment has generated the highest revenue in 2019, accounting for a share of 64.7%
Employment of these products in a diverse range of usages pertaining to DNA modification has been observed in the research and biotechnology studies. In addition, this sector is expected to witness rapid growth with respect to the incorporation of these consumables
North America accounted for the highest share of 38.2% in 2019 and is expected to maintain this dominance through 2020 to 2027, attributed to the high penetration of novel diagnostic techniques
The Asia Pacific is expected to offer lucrative opportunities for market expansion, attributed to the rising focus on the infectious disease diagnosis
A robust network of local manufacturers has significantly contributed to the revenue generated by APAC in the market
Grand View Research has segmented the global healthcare specialty enzymes market on the basis of product, source, usage, application, technique, end-use, and region:
Healthcare Specialty Enzymes Product Outlook (Revenue, USD Million, 2016 - 2027)
Carbohydrases
Polymerases and Nucleases
Proteases
Lipases
Phosphatases/Phytases
Other Products
Healthcare Specialty Enzymes Source Outlook (Revenue, USD Million, 2016 - 2027)
Micro-organisms
Animals
Plants
Healthcare Specialty Enzymes Technique Outlook (Revenue, USD Million, 2016 - 2027)
Clinical Chemistry
Immunodiagnostics/Immunoassays
Molecular Diagnostics
Hematology
Microbiology
Healthcare Specialty Enzymes Usage Outlook (Revenue, USD Million, 2016 - 2027)
Research & Biotechnology
Diagnosis
Healthcare Specialty Enzymes Application Outlook (Revenue, USD Million, 2016 - 2027)
Infectious disease
Diabetes
Oncology
Cardiology
Nephrology
Autoimmune diseases
Healthcare Specialty Enzymes End-use Outlook (Revenue, USD Million, 2016 - 2027)
Hospitals
Laboratory
Others
Healthcare Specialty Enzymes Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
U.S.
Canada
Europe
Germany
U.K.
Asia Pacific
China
Japan
India
Latin America
Brazil
MEA
South Africa
List of Key Players of Healthcare Specialty Enzymes Market
Advanced Enzymes Technologies Ltd
Amano Enzymes, Inc.
Amicogen
BBI Solutions
biotechrabbit GmbH
Brain AG
CPC Biotech
Creative Enzymes
EKF Diagnostics
F. Hoffmann-La Roche Ltd
Merck KGaA
Sekisui Chemical Co., Ltd.
Thermo Fisher Scientific, Inc.
"The quality of research they have done for us has been excellent..."